Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Psychedelics Stock, Up 190% This Year, Flies High Again" is generating significant coverage in the Business category, with 12 articles from 11 distinct sources tracked by PULSE so far.
Outlets currently covering the story include AllSci, TipRanks, Yahoo Finance and Dealroom. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 43d ago.
Quick answers
Why is "Psychedelics Stock, Up 190% This Year, Flies High Again" trending?
Because 11 independent news sources published 12 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (12)
- Definium’s LSD therapy posts second positive Phase III GAD result AllSci · 45d ago
- Definium Therapeutics price target raised to $75 from $70 at Oppenheimer TipRanks · 45d ago
- Definium Reports Second Phase III Success in Anxiety Disorder Program Yahoo Finance · 45d ago
- Definium Therapeutics notches third straight Phase 3 win as DT120 psychedelic hits goals in generalised anxiety disorder Dealroom · 45d ago
- DFTX Maintained by Baird -- Price Target Raised to $79.00 GuruFocus · 45d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder Business Wire · 45d ago
- Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’ BioSpace · 45d ago
- Definium’s LSD therapy eased anxiety in second large trial STAT · 45d ago
- Definium's psychedelic notches another Phase III win in anxiety FirstWord Pharma · 45d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder Yahoo Finance · 45d ago
- Definium's LSD-based anxiety, depression drug scores another trial win Reuters · 45d ago
- Psychedelics Stock, Up 190% This Year, Flies High Again Investor's Business Daily · 45d ago
Topics
Related trends
Intel Stock Is Crashing Out. Here’s Why the Shares Are Dropping Today
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
This electric screwdriver uses a camera and AI to figure out what bit you need
5 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
This Is the Healthiest Way To Drink Tea: 4 Tips To Protect Your Heart With Every Sip
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
“I Can’t Ignore This”: Packers Legend Brett Favre, Diagnosed With Parkinson’s, Admits Terrifying CTE Fears
4 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
19 astonishing images from European Wildlife Photographer of the Year 2026
5 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Amazon Stock Drops on Wall Street Miss, Despite Biggest Cloud Growth in Years
Amazon stock falls on Wall Street misses despite record cloud growth.